Emerging Modalities for Bioprocess Development
Data-Rich Experimentation to Ensure Efficiency, Yield, Purity, and Cost Objectives
نظرة عامة على البرنامج
- In-situ, real-time characterization of particle system composition, size and distribution, morphologies and transformations as a function of CPPs
- Filter characterization as a function of particle size distributions
- Floc size optimization for depth filter performance
- Cell attachment characterization to microcarriers
- Characterization of post-chromatography precipitation challenges
- Characterization and scale-up of process conditions which mitigate upsets and maintain process efficiency
- Overcoming the challenges associated with offline analytical techniques (including inaccuracy and time-delays)
This free online event is for scientists and engineers who are interested in improving process performance by identifying, understanding, and optimizing by modeling critical process parameters involved with processing of drug substances (DS), vaccines, excipients, and/or bioconjugates.
Previous Presenters
EasyViewer: Camera in Bioreactors
Yu-Heng (Vivian) Ma, Ph.D., Scientist, Vaccine Drug Substance Development - Sanofi
AAV Harvest Process Optimization with EasyViewer
Yaozhong Zhang, Principal Scientist, Purification Process Development, Genomic Medicine Unit CMC - Sanofi
Downstream Precipitate Characterization Study Case in Continuous Bioprocessing
David Scherr, Ph.D., Senior Scientist, Bioprocess Technologies & Engineering - AstraZeneca
